Archer-Daniels-Midland Company (ETR:ADM)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	82,776	85,530	93,935	101,556	85,249	64,355
Revenue Growth (YoY)	-6.75%	-8.95%	-7.50%	19.13%	32.47%	-0.47%
Cost of Revenue	77,503	79,752	86,422	93,986	79,262	59,902
Gross Profit	5,273	5,778	7,513	7,570	5,987	4,453
Selling, General & Admin	3,656	3,688	3,451	3,290	3,067	2,591
Other Operating Expenses	112	95	56	21	11	9
Operating Expenses	3,752	3,767	3,513	3,399	3,110	2,647
Operating Income	1,521	2,011	4,000	4,171	2,877	1,806
Interest Expense	-670	-706	-647	-396	-265	-339
Interest & Investment Income	367	562	499	293	47	88
Earnings From Equity Investments	535	621	551	832	595	579
Currency Exchange Gain (Loss)	-78	142	43	194	189	-153
Other Non Operating Income (Expenses)	246	10	209	75	-79	230
EBT Excluding Unusual Items	1,921	2,640	4,655	5,169	3,364	2,211
Merger & Restructuring Charges	-175	-26	-33	-29	-39	-26
Impairment of Goodwill	-	-	-137	-	-6	-
Gain (Loss) on Sale of Investments	-461	-461	-57	-	49	23
Gain (Loss) on Sale of Assets	47	27	38	78	100	138
Asset Writedown	-59	-58	-172	-37	-119	-54
Other Unusual Items	-	-	-	52	-36	-409
Pretax Income	1,406	2,255	4,294	5,233	3,313	1,883
Income Tax Expense	318	476	828	868	578	101
Earnings From Continuing Operations	1,088	1,779	3,466	4,365	2,735	1,782
Minority Interest in Earnings	11	21	17	-25	-26	-10
Net Income	1,099	1,800	3,483	4,340	2,709	1,772
Net Income to Common	1,099	1,800	3,483	4,340	2,709	1,772
Net Income Growth	-57.75%	-48.32%	-19.75%	60.21%	52.88%	28.50%
Shares Outstanding (Basic)	482	492	541	562	564	561
Shares Outstanding (Diluted)	484	493	542	563	566	565
Shares Change (YoY)	-6.84%	-9.04%	-3.73%	-0.53%	0.18%	-
EPS (Basic)	2.28	3.66	6.44	7.72	4.80	3.16
EPS (Diluted)	2.28	3.65	6.43	7.71	4.79	3.15
EPS Growth	-54.58%	-43.23%	-16.60%	60.96%	52.06%	29.10%
Free Cash Flow	4,109	1,227	2,966	2,159	5,426	-3,209
Free Cash Flow Per Share	8.50	2.49	5.47	3.83	9.59	-5.68
Dividend Per Share	2.020	2.000	1.800	1.600	1.480	1.440
Dividend Growth	6.32%	11.11%	12.50%	8.11%	2.78%	2.86%
Gross Margin	6.37%	6.75%	8.00%	7.45%	7.02%	6.92%
Operating Margin	1.84%	2.35%	4.26%	4.11%	3.38%	2.81%
Profit Margin	1.33%	2.10%	3.71%	4.27%	3.18%	2.75%
Free Cash Flow Margin	4.96%	1.44%	3.16%	2.13%	6.37%	-4.99%
EBITDA	2,585	3,063	4,987	5,130	3,840	2,737
EBITDA Margin	3.12%	3.58%	5.31%	5.05%	4.50%	4.25%
D&A For EBITDA	1,064	1,052	987	959	963	931
EBIT	1,521	2,011	4,000	4,171	2,877	1,806
EBIT Margin	1.84%	2.35%	4.26%	4.11%	3.38%	2.81%
Effective Tax Rate	22.62%	21.11%	19.28%	16.59%	17.45%	5.36%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.